Analgosedation in Neonatal Intensive Care: Current Strategies, Challenges, and Future Perspectives

Area of Science:

• Neonatal Intensive Care
• Pediatric Pharmacology
• Pain Management

Background:

• Neonatal intensive care units (NICUs) frequently encounter pain and stress in preterm and critically ill newborns due to invasive procedures and life support.
• Effective analgosedation is crucial for reducing discomfort, stabilizing physiology, and potentially preventing adverse neurodevelopmental outcomes.
• Neonatal pain management is complicated by developmental immaturity and variability in drug responses.

Purpose of the Study:

• To review current evidence on analgosedation in the NICU.
• To focus on clinical indications, pharmacological and non-pharmacological strategies, monitoring, and adverse effects.
• To discuss future directions in neonatal pain and stress management.

Main Methods:

• This narrative review synthesizes existing research on neonatal analgosedation.
• It examines various pharmacological agents like opioids, benzodiazepines, dexmedetomidine, and ketamine.
• It also considers non-pharmacological interventions and assessment tools.

Main Results:

• Individualized selection and careful titration of pharmacological agents are necessary due to variable benefits and limitations.
• Non-pharmacological interventions (e.g., sucrose, skin-to-skin care) should complement pharmacotherapy.
• Validated assessment tools (e.g., COMFORTneo, N-PASS) aid in standardized pain evaluation.

Conclusions:

• Optimizing neonatal comfort requires a multimodal approach integrating pharmacological and non-pharmacological strategies.
• A multidisciplinary, protocol-driven, and family-centered strategy is essential.
• Future advancements may involve objective monitoring, AI, and precision medicine for improved analgosedation.